Infusional Mitoxantrone Plus Bolus Melphalan as a Stem Cell Transplant Conditioning Regimen for Multiple Myeloma

Item

http://www.wikidata.org/entity/Q55014795

description

im Februar 2011 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в лютому 2011

@uk

name

Infusional Mitoxantrone Plus B ...... g Regimen for Multiple Myeloma

@en

Infusional Mitoxantrone Plus B ...... g Regimen for Multiple Myeloma

@nl

type

Item

label

Infusional Mitoxantrone Plus B ...... g Regimen for Multiple Myeloma

@en

Infusional Mitoxantrone Plus B ...... g Regimen for Multiple Myeloma

@nl

prefLabel

Infusional Mitoxantrone Plus B ...... g Regimen for Multiple Myeloma

@en

Infusional Mitoxantrone Plus B ...... g Regimen for Multiple Myeloma

@nl

P1476

Infusional Mitoxantrone Plus B ...... g Regimen for Multiple Myeloma

@en

P2093

Andrew Sharf

http://www.w3.org/2001/XMLSchema#string

Anne W. Beaven

http://www.w3.org/2001/XMLSchema#string

Dominic T. Moore

http://www.w3.org/2001/XMLSchema#string

Don A. Gabriel

http://www.w3.org/2001/XMLSchema#string

Thomas C. Shea

http://www.w3.org/2001/XMLSchema#string

P2860

A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors

Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies.

A phase I pharmacokinetic study of 21-day continuous infusion mitoxantrone.

A randomized study of MOD versus VAD in the treatment of relapsed and resistant multiple myeloma.

Bolus and continuous infusion mitoxantrone in newly diagnosed adult acute lymphoblastic leukemia: results of two consecutive phase II clinical studies.

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study.

A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia.

A clinical and pharmacokinetic study of mitoxantrone in acute nonlymphocytic leukemia.

Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma.

P304

214-219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/07357907.2010.550663

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan S. Serody

P577

2011-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21314330

http://www.w3.org/2001/XMLSchema#string